News and Announcements
BPS Investor Presentation Update June 2016
- Published June 21, 2016 4:36PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
21st June 2016, ASX Announcement
BPS Technology Half year Highlights
- Revenue of $25.1 million, exceeding prior corresponding period (H1FY15: $24.9 million)
- EBITDA of $4.7 million, up 4% (H1FY15: $4.5 million)
- Earnings per share of 6.0c, up 7.2% (HY15: 5.6c)
- Interim dividend of 2.0 cents per share unfranked declared
- New Sales Model resulted in 39% growth in new Merchants
- Bartercard USA operations revenues up 124%
- Acquisition of further 2 large franchises in Australia – over 70% of Members now managed by company owned sites
- bucqi launched in 3 Queensland regional centres with more than 200+ Merchants and 2,000+ Consumers participating
- TESS delivered software to IRTA that saw record levels of trading recorded – highest ever achieved
- Laid the foundation for growth for FY17
- Executive directors and management team own 55% of issued shares
- Well positioned to capitalise on various growth opportunities on our platforms
To view the full presentation, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
